Many consumers today prioritize social-minded businesses and food establishments when they decide where to spend their dollars. That's why the new app, Beam, has made social good the core of their business and mission.
Viveka Hulyalka is the co-founder and CEO of Beam. She joins Cheddar to explain how her app is driving consumer engagement and helping brands build their social engagement arm.
Currently, Beam is partnered with brands like Think Coffee, Dig Inn, and Pinkberry. When a consumer visits one of the partner locations they have the ability to choose one of their four charities and donate between five cents and 25 cents.
Hulyalka explains that Beam is a completely free way to help consumers give back every day.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
